Frank Rimerman Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
2,485
+104
+4% +$27.6K 0.07% 210
2026
Q1
$261K Buy
2,381
+8
+0.3% +$1.14K 0.02% 526
2025
Q4
$395K Sell
2,373
-244
-9% -$40.8K 0.03% 440
2025
Q3
$512K Buy
2,617
+254
+11% +$41.8K 0.03% 366
2025
Q2
$214K Buy
+2,363
New +$187K 0.01% 534

Other funds holding ALAB

Frank Rimerman Advisors's ALAB Position: Q2 2026 in Review

Frank Rimerman Advisors increased its Astera Labs (ALAB) stake by 4.4% in Q2 2026, buying an estimated $27.6K and bringing the position to 2,485 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #210.

Frank Rimerman Advisors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Frank Rimerman Advisors held 2,485 shares of Astera Labs worth $1.2M as of Q2 2026.
  • Frank Rimerman Advisors bought 104 Astera Labs shares in Q2 2026, an estimated $27.6K.
  • Astera Labs made up 0.07% of Frank Rimerman Advisors's portfolio in Q2 2026, its #210 holding.
  • Frank Rimerman Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.